
Trouble sleeping? These are the 7 products our editors swear by for a good night's sleep
After our fair share of restless nights, mattress testing, bedding shopping and sleep tech reviewing, we're confident we know what it takes to get a good night's sleep. Optimizing our sleep is part of our day job, after all.
As well as sleeping on and testing the best mattresses of the year, there are a handful of products our writers and editors simply can't sleep without. From the humble ear plugs and socks to more technical products, like sleep trackers and sleep headbands, this is a list of the gear the Tom's Guide Sleep Team rely on for a good night's sleep.
SPONSORED
Sealy Posturepedic Elite Hybrid : Getting the sleep you need improves a litany of issues, but you can't get that sleep if you're waking up stiff and sore. The targeted support of a Sealy Posturepedic® Elite Hybrid mattress helps provide relief where you need it most. This bed flexes to your unique shape, making sure you find the personalized support you need to perform your best in the morning.
7 products our editors swear by for better sleep
We'll be honest, not all the products we test perform as well as their makers promise they do. But these aren't the products we're focusing on here. Instead, you'll find our favorite, trusty gadgets that have actually sent us to sleep fast and keep us snoozing all night long...
1. Loop Dream Earplugs: $49.95 at Loop Earplugs
Be it a busy street outside your bedroom window, noisy neighbours or a snoring partner, noise pollution is a common sleep disruptor. But with the Loop Dream Earplugs, our Sleep Editor Nicola Appleton sleeps soundly. She says: 'After 14 years of sleeping next to someone who snores, I tried the Loop Dream Earplugs — the first sleep-specific option from Loop — and haven't looked back. With a noise reduction rating of 27dB (SNR), they block out my partner's snoring completely — which means I can finally get an undisturbed night's rest. With their ultra-soft silicone and a flat, closed-loop design, they're also ideal for side sleepers like me. And, with four ear tip sizes, they stay securely in place all night. If someone else's snoring is keeping you awake, these ear plugs will save your sleep.'
2. Samsung Galaxy Ring: $399.99 at Samsung
While we're aware sleep trackers don't directly improve your sleep, we use them to learn more about our sleep patterns and tendencies. Our Sleep Features Editor Lauren Jeffries has been testing the Samsung Galaxy ring. Here's what she has to say about it's sleep tracking functionality: "I've never used any kind of sleep tracker before the Galaxy Ring. Yes, I had nightmares and probably didn't get enough sleep most nights, but in general, I felt well rested. The Galaxy Ring has educated me so much that I'm now getting better sleep every night. This is mainly because of the sleep score. I love how detailed it is, looking at every aspect that went into calculating it, from sleep duration and my bedtime, to the amount of REM sleep I got and how long it took me to fall asleep. Since using it, my sleep schedule has become more consistent and I prioritize getting quality rest over quantity, which has also helped my nighttime anxiety."
3. Women's Fine Cashmere and Merino Wool Super Soft Socks: $29.99 at Amazon
Wearing socks to bed is a disputed topic on our sleep team. While some say it makes them feel claustrophobic, others enjoy their sleep-enhancing benefits, and science suggests the latter group are right. Nicola says: 'Wearing socks to bed is a simple, science-backed habit with a big payoff — falling asleep faster and staying asleep longer. Instead of making you hot, socks gently warm your feet, triggering vasodilation, which actually helps lower your core temperature — a critical cue for falling asleep. Cold feet, on the other hand, can delay sleep onset and lead to restless tossing and turning. In the warmer summer months always opt for a lightweight, breathable fabric like cotton or cashmere.' This pair from Amazon are reasonably priced and come in 14 color options.
4. Philips SmartSleep Sleep and Wake-Up Light: $213.22 at Amazon
A top sunrise alarm clock is a staple on my bedside table now, no matter the season. As a sleep tech writer, my current favorite is the Philips SmartSleep Wake-Up Light. In winter, it helps me wake up to light. Even though the mornings are naturally light now, I still enjoys using the sunset simulation as part of my wind down routine. Plus the gentle wake up sounds are much better than a jolting iPhone alarm. The Philips is a more expensive sunrise alarm clock option, but functioning as a bedside reading lamp too, I think it's worth the splurge.
5. Elemind sleep headband: $349 at Elemind
The Elemind headband is part of the emerging sleep headband market. Placed over your forehead, the headband measures EEG brain signals and delivers precise acoustic stimulation that moves the brain from wakeful patterns into a deeper sleep. I have been using this headband to get more deep sleep while marathon training. I've slept all night long wearing it and can vouch for its efficiency considering I stayed asleep even when my brother came into my bedroom to steal an iPhone charger plugged in next to my bed (though he was slightly confused by my sleep accessory). At $349, this is a premium sleep product, which will only be worth it if you're really struggling to switch off at night.
6. Feather & Down Sweet Dream Pillow Spray: $17 at Amazon
Essential oils like lavender and chamomile are known to calm the nervous system, promoting overall relaxation. Our Senior Sleep Writer, Frances Daniels, uses the Feather & Down Sweet Dream Pillow Spray to make the most of this relaxation technique. She says: "Spritzing my bedding with lavender pillow spray has become a comforting bedtime ritual for me, and helps me to fall asleep faster. It may just be a placebo effect, but studieshave shown that the soothing scent can increase sleep quality and ease anxiety." At just $17, this is an affordable sleep product.
7. MZOO Sleep Eye Mask: was $28.99 now $22.99 at Amazon
Light is a major sleep killer for our Senior Sleep Writer, Ruth Jones, so she relies on a comfy eye mask to create the perfect environment for rest, whether she's on her friend's sofa or a cross-Atlantic airline. She says: "My eye mask blocks the lights that plague my bedroom — like the smoke detector and power strip — and it also helps me put my phone away at night. After all, once my eye mask is on, I can't check my messages any more. Just the action of putting an eye mask on has come to signal to my brain that it's time to go to sleep and I find it's weight on my face strangely comforting now." The MZOO is a great value, great quality sleep mask option with 21% off at Amazon now, bringing the price to $22.99. Yes it's a bit more than your average silk mask, but made with soft fabric, it'll be more durable.
Sign up to get the BEST of Tom's Guide direct to your inbox.
Get instant access to breaking news, the hottest reviews, great deals and helpful tips. Contact me with news and offers from other Future brands Receive email from us on behalf of our trusted partners or sponsors
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
2 days ago
- Business Wire
Align Technology Connects With Over 2,000 Doctors and Practice Staff at the 2025 Invisalign ® Asia Pacific (APAC) Summit
BANGKOK--(BUSINESS WIRE)--Align Technology, Inc. ('Align') (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from the 2025 Invisalign ® Asia Pacific ('APAC') Summit held in Bangkok, Thailand, June 5 – 7, 2025. 'With more than 3 million Invisalign smiles across Asia Pacific, we know that this region sees some of the toughest clinical challenges in the field of dentistry,' said David Carr, Align executive vice president and managing director, APAC. 'The 2025 Invisalign Asia Pacific Summit underscores the importance of continued innovation and education. We are committed to working in partnership with doctors across the region in developing Invisalign treatment protocols that can help them transform smiles and change lives for even more patients.' Over three days, more than 2,000 doctors, practice team members, partners, and Align staff from across the region came together to explore the latest innovations in digital orthodontics and restorative dentistry. The summit featured over 60 expert speakers and more than 50 immersive breakout lectures and hands-on workshops, all designed to help doctors elevate clinical outcomes, streamline workflows, and grow their practices. Key topics covered include kids and teen, complex treatments, comprehensive dentistry and practice growth. 'This meeting provided us with a platform to connect with doctors across the full Asia Pacific region, encourage ongoing learning and sharing and showcase how our global innovations can support doctors in this market,' said Gigi Tsui, Align senior director, clinical, APAC. 'As we celebrate 20 million Invisalign smiles globally, including 3 million Invisalign smiles across the Asia Pacific region, it's critical that we continue to engage doctors for feedback and insights. This is fundamental to developing new innovations that meet the unique needs of doctors and patients across this region.' Attendees explored new developments across multiple interactive zones in the Innovation Hub, including: Kids and Teens: Featuring Invisalign First™, Invisalign® Palatal Expander System, and Invisalign® System with mandibular advancement featuring occlusal blocks ('MAOB'). ClinCheck® signature experience: Highlighting the 1-page Rx form (Flex Rx), preference templates, and ClinCheck ® Live Update. Comprehensive Dentistry: Showcasing iTero Lumina™ Pro dental imaging system, iTero™ intraoral scanner, Invisalign Smile Architect™, and Invisalign® Smile Video. Consumer & Branding: Demonstrating branding and tools to help doctors raise awareness of digital treatment options among patients of all ages. Clinical Excellence: Sharing clinical tools, evidence-based resources, education and insights available to doctors and staff. The summit also featured a Women Leadership session and provider recognition and lifetime achievement awardees. In addition to the core Asia Pacific Invisalign Summit, over 300 delegates across 78 universities also attended the Align APAC University Forum hosted at the renowned Chulalongkorn University in Bangkok. The forum served as a dynamic platform for cross-border collaboration and meaningful dialogue on how Align's evidence-based approach and cutting-edge innovations complements academic excellence and clinical training. Key highlights included keynote presentations by industry experts, interactive case-based discussions, resident showcases, and panels on integrating aligner therapy into university curriculum. The event also celebrated academic excellence with the APAC Case Challenge and Align research awards for APAC, while fostering peer-to-peer collaboration and inspiring the next generation of orthodontic leaders. About Align Technology, Inc. Align Technology designs and manufactures the Invisalign ® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 281.4 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.


Business Wire
2 days ago
- Business Wire
Foldax Announces Positive One-Year Data on TRIA Mitral Valve
SALT LAKE CITY--(BUSINESS WIRE)--Foldax® Inc., a leader in the development of innovative polymer heart valves, today announced compelling one-year results from the India Clinical Trial of the TRIA™ Mitral Valve, showing a good safety profile, sustained hemodynamic performance, and statistically significant improvement in patient quality of life. These are the first one-year outcomes ever presented for a multicenter clinical study of a polymer heart valve worldwide. Results were presented today at New York Valves 2025, the annual conference organized by the Cardiovascular Research Foundation (CRF), and concurrently published in the Journal of the American College of Cardiology (JACC). 'It is exciting to see the positive clinical outcomes associated with this novel polymer valve.' Isaac George, M.D., Surgical Director of the Heart Valve Center at Columbia University. Share Key one-year results from the trial showed: No valve-related mortality or reinterventions >50% reduction in mean gradient (9.7 mmHg to 4.5 mmHg) and >90% increase in effective orifice area (0.9 cm² to 1.5 cm²), the highest reported in similar surgical mitral valve studies 24-point improvement in KCCQ score (57.5 to 81.9) and 65% increase in Six-Minute Walk Test distance (298.1 m to 494.8 m), indicating significant improvement in quality of life The prospective, multicenter trial enrolled 67 patients aged 19 to 67 across eight sites in India, with an average age of 42. Notably, 64% were women, and of these, nearly half were of childbearing age, a significantly larger percentage than typically seen in clinical studies. Seventy-three percent of patients had rheumatic heart disease. 'It is exciting to see the positive clinical outcomes associated with this novel polymer valve,' said Isaac George, M.D., Surgical Director of the Heart Valve Center at Columbia University. 'This new type of valve sets out to reimagine how a device can address clinical needs that are underserved by current valve solutions.' 'I am proud to be the principal investigator in India for this groundbreaking trial and represent the highly esteemed clinical investigators who participated in the study,' said Kaushal Pandey, M.D., Principal Investigator of the TRIA Mitral Valve India Clinical Trial and Cardiac Surgeon at P.D. Hinduja Hospital in Mumbai. 'The TRIA Mitral Valve provides hope for Indian patients—including younger patients and many women of childbearing age—for whom current valve options often fall short.' Foldax's vision for its novel polymer heart valves is to address the limitations of tissue and mechanical options by making its valves durable, with the future goal of avoiding a requirement for lifelong anticoagulation. TRIA valves incorporate a proprietary polymer—LifePolymer™ —formulated to be calcium-resistant, biostable and biocompatible. The novel polymer material enables TRIA valves to be robotically produced, which is designed to increase manufacturing efficiency and maximize product quality and precision. 'These results validate our strategy of taking heart valve therapy to a new level by bringing innovation to a platform of products that will help patients globally,' said Ken Charhut, CEO of Foldax. The Journal of the American College of Cardiology (JACC) publication can be viewed at: *The TRIA Mitral Valve is approved for use in India by CDSCO. The TRIA Mitral Valve is for investigational use only and is not available for commercial sale in the U.S. Headquartered in Salt Lake City, Utah, Foldax is reinventing every aspect of the heart valve—from material to design to manufacturing—to develop surgical and transcatheter valves with the potential to last a lifetime, addressing limitations of tissue and mechanical valves. Foldax investors include Angel Physicians Fund, Biostar Capital, Caltech, Glenview Capital, Kairos Ventures, Memorial Care Innovation Fund and Sayan Bioventures. For more information on the TRIA Mitral Valve and Foldax's commitment to revolutionizing heart valve care, visit
Yahoo
2 days ago
- Yahoo
Cigna Enables Coverage for RhinAer®
Policy Update Validates Clinical Value and Expands Patient Access to Innovative Chronic Rhinitis Treatment MOUNTAIN VIEW, Calif., June 27, 2025--(BUSINESS WIRE)--Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced that Cigna Healthcare will provide coverage for RhinAer® treatment of the posterior nasal nerve (CPT 31242), effective September 15, 2025. This change removes RhinAer from Cigna's list of procedures deemed experimental, investigational, and unproven, marking a significant step forward in expanding access to a best-in-class treatment option for patients suffering from the debilitating effects of chronic rhinitis. Starting September 15, over 15 million Cigna members and their healthcare providers will gain access to this clinically proven solution for patients with chronic rhinitis, a persistent inflammatory condition that significantly compromises quality-of-life. Cigna's policy update highlights the growing recognition of RhinAer's clinical efficacy and net health benefit as a non-invasive alternative to surgery or long-term, ineffective medication and clinic-based management. "Cigna's decision is a pivotal milestone in expanding physician and patient access to RhinAer — already used to treat more than 50,000 patients," said Matt Brokaw, CEO of Aerin Medical. "Alongside recent coverage expansion by Blue Cross of Idaho, this momentum underscores the compelling evidence for this procedure and its significant benefit for sufferers. We are grateful for our partnership with the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) and EVP/CEO Dr. Rahul K. Shah, MD, MBA, and for the significance of our combined voice in elevating awareness of this condition's burden." "Chronic rhinitis takes a substantial toll on patients and Cigna's decision is a welcome development that empowers physicians to offer critical solutions to appropriate patients," said Dr. Gavin Setzen, CEO & President of Albany ENT & Allergy Services, P.C., and Associate Clinical Professor of Otolaryngology-Head & Neck Surgery at Albany Medical Center, and past president of AAO-HNS. "With strong evidence from 20 peer-reviewed publications and multi-study evidence of three-year durability, we know that RhinAer works. I am pleased that Cigna's decision supports the adoption of a therapy that elevates the standard of care for patients." Information for Providers: The codes 31242 - Nasal/sinus endoscopy, surgical; with destruction by radiofrequency ablation, posterior nasal nerve and 31243 - Nasal/sinus endoscopy, surgical; with destruction by cryoablation, posterior nasal nerve have been removed from experimental / investigational status and will not require precertification. For more information about Cigna's updated medical policy for RhinAer (CPT 31242), visit: About RhinAer Using temperature-controlled, radiofrequency technology, RhinAer features a thin, wand-like stylus that is inserted via the nostril to deliver precise therapeutic benefits, while sparing surrounding tissues. RhinAer directly disrupts the posterior nasal nerve (PNN) that triggers excessive mucus production, treating an underlying cause of chronic rhinitis. RhinAer provides ENT physicians with a comprehensive solution for the treatment of chronic rhinitis, addressing sources of rhinorrhea and congestion. The procedure can be performed with a local anesthetic during an office visit, with no incisions, minimal to no downtime, and little discomfort. RhinAer initially received FDA 510(k) clearance in December 2019 and CE Mark in 2020. For more information, visit About Aerin Medical Aerin Medical is a privately held, venture-backed company, headquartered in Mountain View, California. Aerin's mission is to expand access to meaningful relief for millions of patients suffering from chronic ENT conditions. The company's products, VivAer® for nasal airway obstruction and RhinAer® for chronic rhinitis, leverage Aerin's proprietary temperature-controlled technology, which allows ENT physicians to reliably improve patients' symptoms with unique technologies that are appealing alternatives to invasive surgery. More than 150,000 patients have been treated with Aerin Medical products to date. For more information, please visit and follow Aerin Medical on Facebook, X, Instagram, LinkedIn and YouTube. View source version on Contacts Media Contact: Michael FanucchiAerin Medicalmfanucchi@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data